We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.
Ever wonder what an induced pluripotent stem cell looks like? Stop by 2001 6th St SE and look up! The new Driven to Transform Health Care window graphic has been installed. At the bottom, the blue and green structure is an induced pluripotent stem cell that has been instructed to become a neural cell.
The University depends on the wide array of skills of its scientists. The original image below was taken by expert microscope photographer Megan Riddle. It takes serious skills to get a picture of a cell that can be enlarged to 12 feet high!
Our Education Programs
The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:
In the News
The safety and uses of stem cell therapy are being reviewed by the FDA at open meetings on September 12-13, 2016. View meeting information here. Read "Cell-therapy rules stir debate" by Heidi Ledford published at Nature.com to learn more.
View the meeting live at: https://videocast.nih.gov/summary.asp?live_19816&bhcp=1
Stem Cell Institute faculty member Paolo Provenzano, PhD, will lead one of two projects as part of an $8.2 million, 5-year National Cancer Institute (NCI) grant, “Center for Modeling Tumor Cell Migration Mechanics.” The University of Minnesota is one of five new centers added to the Physical Sciences Oncology Network (PSOC) this year. This network meets regularly and works collaboratively to advance research more effectively. The University of Minnesota center is led by David Odde, PhD, as Center MPI (also a project leader) along with David Largaespada, PhD, and Steven Rosenfeld, MD, PhD, at the Cleveland Clinic.
The Stem Cell Institute receives many inquiries from patients wanting to know if stem cell therapies are safe and available to help them. It can be confusing to sort out what is claimed from what has been proven. In February The Food and Drug Administration issued draft guidelines clarifying that the stem cells used in most clinics are drugs and require a rigorous approval process before they can be used in patients. Read the FDA Consumer Update on stem cell therapies. In September 2016, the FDA will be holding public meetings to hear comments on the draft guidelines. UPDATE: read an example of an FDA warning letter <<here>>.
Patients considering stem cell therapies can find reputable information at the International Society for Stem Cell Research (ISSCR) website: www.closerlookatstemcells.org.